Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy

Tumor treatment is still complicated in the field of medicine. Tumor immunotherapy has been the most interesting research field in cancer therapy. Application of chimeric antigen receptor T (CAR-T) cell therapy has recently achieved excellent clinical outcome in patients, especially those with CD19-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yanyu, Hou, Xiaoyang, Yang, Chunsheng, Liu, Yanqun, Jiang, Guan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956614/
https://www.ncbi.nlm.nih.gov/pubmed/29769134
http://dx.doi.org/10.1186/s12943-018-0840-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956614/
https://www.ncbi.nlm.nih.gov/pubmed/29769134
http://dx.doi.org/10.1186/s12943-018-0840-y

Ejemplares similares